Published 4 years ago

Canada signs deals for supply of Sanofi vaccine candidate, antiviral drug to treat COVID-19

Summary by CTV News

OTTAWA -- The federal government has inked a new deal with French multinational pharmaceutical firm Sanofi to obtain 72 million doses of its protein-based COVID-19 vaccine candidate.

0 Articles

All

Left

Center

Right

Yahoo News

Sanofi and GSK sign agreements with the Government of Canada to supply up to 72 million doses of adjuvanted COVID-19 vaccine

* Signed agreements relate to vaccine candidate using Sanofi's recombinant protein-based technology combined with GSK's pandemic adjuvant * Both companies are committed to making their COVID-19 vaccine affordable and available globally TORONTO, Sept. 22, 2020 /CNW/ - Today, Sanofi and GSK announce

4 years ago·Los Angeles, United States

Read Full Article

CTV News

Canada signs deals for supply of Sanofi vaccine candidate, antiviral drug to treat COVID

The federal government has inked a new deal with French multinational pharmaceutical firm Sanofi to obtain 72 million doses of its protein-based COVID-19 vaccine candidate.

4 years ago·Canada

Read Full Article

Reuters

Sanofi and GSK have signed an agreement with Canada to supply their vaccine candidate

PARIS - Sanofi and GSK announced on Tuesday that they had signed agreements with the Government of Canada to provide it, starting in 2021, with up to 72 million doses of their adjuvanted vaccine candidate against COVID-19. "Today's announcement illustrates our unwavering desire to develop a vaccine against COVID-19 that is accessible to all as soon as it hits the market," commented in

4 years ago·United Kingdom

Read Full Article

CBC News

Canada nails down 5th deal for potential COVID-19 vaccine

Canada has committed $1 billion to buy at least 154 million doses of vaccines from five different companies, and most of that money will not be refunded even if the vaccines never get approved.

4 years ago·Canada

Read Full Article

680 News

Canada reaches agreement on coronavirus vaccine with 2 companies

LONDON — Pharmaceutical giants GlaxoSmithKline and Sanofi have agreed to provide Canada with up to 72 million doses of their potential COVID-19 vaccine as governments buy up supplies of unproven treatments in hopes of ensuring supplies of whatever works.On Tuesday, the companies reiterated their commitment to make the vaccine affordable and available globally.“Both companies have significant R&D and manufacturing capability worldwide and are alr…

4 years ago·Toronto, Canada

Read Full Article

The Globe & Mail

Canada secures supply of remdesivir, more COVID-19 vaccine doses

In all, Canada has committed $1-billion to buy at least 154 million doses of vaccines from five different companies, and most of that money will not be refunded even if the vaccines never get approved

4 years ago·Canada

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.

Coverage Details

Total News Sources0

Leaning Left2Leaning Right0Center6Last Updated4 years agoBias Distribution

75% Center

Bias Distribution

75% of the sources are Center

75% Center

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Canada signs deals for supply of Sanofi vaccine candidate, antiviral drug to treat COVID-19

0 Articles

0 Articles

Sanofi and GSK sign agreements with the Government of Canada to supply up to 72 million doses of adjuvanted COVID-19 vaccine

Sanofi and GSK sign agreements with the Government of Canada to supply up to 72 million doses of adjuvanted COVID-19 vaccine

Canada signs deals for supply of Sanofi vaccine candidate, antiviral drug to treat COVID

Canada signs deals for supply of Sanofi vaccine candidate, antiviral drug to treat COVID

Sanofi and GSK have signed an agreement with Canada to supply their vaccine candidate

Sanofi and GSK have signed an agreement with Canada to supply their vaccine candidate

Canada nails down 5th deal for potential COVID-19 vaccine

Canada nails down 5th deal for potential COVID-19 vaccine

Canada reaches agreement on coronavirus vaccine with 2 companies

Canada reaches agreement on coronavirus vaccine with 2 companies

Canada secures supply of remdesivir, more COVID-19 vaccine doses

Canada secures supply of remdesivir, more COVID-19 vaccine doses

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics